Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06286800 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 9 months later Mar 14, 2027 → Dec 30, 2028
Primary endpoint added 1 → 2 primary endpoints
See other at-risk trials from The Methodist Hospital Research Institute

Record History

  1. Primary completion pushed from Mar 14, 2027 to Dec 30, 2028 Primary endpoint(s) modified · Completion pushed from Sep 14, 2027 to Sep 30, 2029 · Eligibility criteria expanded, about 14 words · 2 more Show 5 more changesShow less
    • Primary endpoint(s) modified
    • Completion pushed from Sep 14, 2027 to Sep 30, 2029
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: 2 to 1
    • Study description revised
  2. Primary completion date: Mar 14, 2026 to Mar 14, 2027 Completion date: Sep 14, 2026 to Sep 14, 2027v4 Show 1 more changeShow less
    • Completion date: Sep 14, 2026 to Sep 14, 2027
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Dec 14, 2024 to Dec 18, 2024v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 14, 2024 to Dec 18, 2024
  4. Start date: Mar 14, 2024 to Dec 14, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.
Trial Details
NCT Number NCT06286800
Lead Sponsor The Methodist Hospital Research Institute
Conditions Stroke, Chronic Stroke, Hemorrhage Brain, Ischemic Stroke
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov